Growth Stocks

ABMD @ $17.28 (Abiomed) develops medical devices designed to assist or replace the pumping function of a failing heart. They've traded almost 5 million shares over the last two days, which is heavy for a stock that averages only 235K shares a day. We are establishing half a position here and will enter the remaining half on a pull back to the $15.50 level. Our stop loss will be set at $14.

This newsletter has been sent to you for informative purposes only and in no event should be construed as a representation by The Stock Playbook or its employees as an offer to sell or solicitation of an offer to buy any securities. The factual information given is taken from sources we believe to be reliable, but is not guaranteed as to its accuracy or completeness. The opinions expressed should be given only such weight as opinions warrant.  employees and/or family members may have a position in the securities mentioned and may make purchase and/or sales of such securities from time to time in the open market or otherwise Recipients of The Stock Playbook prohibited from, directly or indirectly, distributing, forwarding , plagiarizing or copying any part of this message without expressed written consent from The Stock Playbook. Some content may have been based, at least in part, on material gathered from Investor's Business Daily ® and/or YAHOO!®